Cangene
| Industry | pharmaceutical industry; contract manufacturing industry |
|---|---|
| Founded | 1984 in Winnipeg, Manitoba, Canada |
| Defunct | 2014 |
| Fate | Acquired by Emergent BioSolutions |
| Divisions | Cangene bioPharma (CMO) |
Cangene Corporation was a biopharmaceutical company based in Winnipeg, Manitoba, Canada. It was founded in 1984 and specialized in hyperimmunes, contract manufacturing, biopharmaceuticals and biodefense. Cangene was 61% owned by Canadian pharmaceutical giant Apotex and was publicly listed on the TSX under the symbol CNJ.